--- title: "Apogee Acquisition raises $177.2M in IPO and sponsor placement; $173.36M held in trust" type: "News" locale: "en" url: "https://longbridge.com/en/news/282747484.md" description: "Apogee Acquisition raised $177.2 million through its IPO and sponsor placement, with $173.36 million placed in trust. The IPO involved 17.25 million units priced at $10 each, including a full over-allotment of 2.25 million units, generating $172.5 million gross. A simultaneous private placement of 470,000 units raised $4.7 million. The audited balance sheet as of April 8, 2026, shows total assets of $174.1 million and cash held in trust of $173.36 million. Deferred underwriting commissions totaled $6 million, with transaction costs of $8.97 million." datetime: "2026-04-14T21:23:01.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/282747484.md) - [en](https://longbridge.com/en/news/282747484.md) - [zh-HK](https://longbridge.com/zh-HK/news/282747484.md) --- # Apogee Acquisition raises $177.2M in IPO and sponsor placement; $173.36M held in trust **Apogee Acquisition raised $177,200,000 from its public offering and sponsor private placement and placed $173,362,500 in trust.** **Key Highlights:** - Completed IPO of 17,250,000 units at $10.00 each, including full 2,250,000 unit over-allotment, generating $172,500,000 gross. - Simultaneous private placement of 470,000 units to sponsor for $4,700,000. - $173,362,500 (approximately $10.05 per unit) of net proceeds placed in a trust account for public shareholders. - Audited balance sheet as of April 8, 2026 shows total assets $174,101,426 and cash held in trust $173,362,500. - Deferred underwriting commission of $6,000,000 recorded; transaction costs totaled $8,972,198. Original SEC Filing: Apogee Acquisition Corp \[ AACPU \] - 8-K - Apr. 14, 2026 **Disclaimer** This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC. ### Related Stocks - [AACPU.US](https://longbridge.com/en/quote/AACPU.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) ## Related News & Research - [Novo Nordisk rolls out Ozempic pill in the U.S.](https://longbridge.com/en/news/284916382.md) - [Major Investor Makes Bold New Move on Seaport Therapeutics Stock](https://longbridge.com/en/news/285144653.md) - [PU Prime Champions Global Excellence as Regional Sponsor of AFA with the Launch of “PU World Cup 2026”](https://longbridge.com/en/news/285041372.md) - [Pyrophyte Acquisition Adds $1.2M Extension Note, Extends Convertible Working Capital Facility to 2027](https://longbridge.com/en/news/284453478.md) - [07:55 ETInFocus Clinical Research names Elizabeth Nanouris Vice President of Business Operations](https://longbridge.com/en/news/285066880.md)